Diseases of the Cardiovascular System, Phase II

A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension

Volunteers
Health Professionals

What is the purpose of this trial?

This is a research study that aims to evaluate the effectiveness of sirolimus in individuals with pulmonary hypertension.

Trial with
AI Therapeutics
Ages
18 years and older
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Anna Hessler

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Phillip Joseph, MD
Assistant Professor; Associate Director, Pulmonary Vascular Disease Program

Sub-Investigator

Inderjit Singh, MBChB, BMedSci, FRCP, FCCP

Last Updated
03/25/2024
Study HIC
#2000035353